ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0910

17β-estradiol and B-cell Intrinsic Type I Interferon Amplify Toll-like Receptor 7 Signaling Loop in B Cells of Female Lupus Prone BXD2 Mice

Kathryn Sullivan, Yong Wang, Winn Chatham, John Mountz and Hui-chen Hsu, University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2023

Keywords: Autoantibody(ies), B-Cell Targets, interferon, sex hormones, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0899–0933) SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: While systemic lupus erythematosus (SLE) disproportionally affects women versus men, elevation in estradiol (E2) alone is not sufficient to promote the development of autoantibody producing B cells. The objective of the present study is to determine if B-cell intrinsic mechanisms contribute to the increased TLR7 response to E2 stimulation.

Methods: Serum levels of E2 and anti-Smith (Sm), and expression of IFNb in naïve B cells were evaluated in African American (AA) SLE patients (24-41yr-old), compared to older AA (42-56yr-old) and European American SLE patients (24-66-yr-old). Similarly, serum levels of E2, anti-Smith (Sm), anti-DNA, and anti-Sm/RNP were compared between female lupus prone BXD2 mice post-puberty (12-wk-old) versus pre-puberty (4-6-wk-old). TLR7-induced expression of interferon-beta (IFNb) and CD69 in transitional stage 1 (T1: CD23–IgM+ CD93+) B cells after stimulation with E2 with or without TLR7 agonist R848 were evaluated using female BXD2 mice, compared to male mice.

Results: We identified that there were elevated circulating levels of E2 in young African American (AA) SLE patients (24-41yr-old), compared to older AA (42-56yr-old) and European American SLE patients (24-66-yr-old). Circulating E2 levels positively correlated with the levels of anti-Smith (Sm) and the expression of IFNb in naïve B cells of SLE patients (n=39). Mouse studies were used to determine if E2 stimulates the expression of IFNb in B cells and if sex plays a role to influence B cell responses to E2.Serum levels of Sm/RNP and RNP autoAbs positively correlated with the levels of E2 in female lupus prone BXD2 mice post-puberty (12-wk-old) but not pre-puberty (4-6-wk-old).At the post-puberty stage ( >12 wk-old), there were significantly elevated levels of anti-DNA and anti-Sm in female BXD2 mice, compared to male mice.This was associated with an increased TLR7-induced expression of interferon-beta (IFNb) and CD69 in transitional stage 1 (T1: CD23–IgM+ CD93+) B cells in female BXD2 mice, compared to male mice. Interestingly, E2 stimulation promoted intracellular levels of IFNb and TLR7 in T1 B cells from female but not male BXD2 mice.

Conclusion: Together, our results suggest that elevation of E2 in combination with an increased B-cell susceptibility to E2 induction of IFNb may play a role in the increased B cell responses to TLR7 stimulation in individuals predisposed to the development of SLE.


Disclosures: K. Sullivan: None; Y. Wang: None; W. Chatham: None; J. Mountz: None; H. Hsu: None.

To cite this abstract in AMA style:

Sullivan K, Wang Y, Chatham W, Mountz J, Hsu H. 17β-estradiol and B-cell Intrinsic Type I Interferon Amplify Toll-like Receptor 7 Signaling Loop in B Cells of Female Lupus Prone BXD2 Mice [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/17%ce%b2-estradiol-and-b-cell-intrinsic-type-i-interferon-amplify-toll-like-receptor-7-signaling-loop-in-b-cells-of-female-lupus-prone-bxd2-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/17%ce%b2-estradiol-and-b-cell-intrinsic-type-i-interferon-amplify-toll-like-receptor-7-signaling-loop-in-b-cells-of-female-lupus-prone-bxd2-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology